Ignite Creation Date:
2024-05-05 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00460746
Status:
COMPLETED
Last Update Posted:
2013-07-31
First Post:
2007-04-13
Brief Title:
EnfuvirtideCurrent Protease Inhibitor Switch to PREZISTA DarunavirRitonavir TMC125 in HIV Patients With Enfuvirtide Side Effects
Sponsor:
Tibotec Inc
Organization:
Tibotec Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05
Start Date Type:
None
Primary Completion Date:
2008-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-10
Completion Date Type:
ACTUAL
First Submit Date:
2007-04-13
First Submit QC Date:
April 13 2007
Study First Post Date:
2007-04-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2009-11-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-07-24
Last Update Post Date:
2013-07-31
Last Update Post Date Type:
ESTIMATED